This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tae Life Sciences, LLC. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: An Overview of Inventor Fuhuhiko Tamanoi and His Contributions
Introduction
Fuhuhiko Tamanoi, an innovative inventor based in Kyoto, Japan, has made significant strides in the field of biomedical engineering. His work primarily focuses on the development of biodegradable nanocarriers that play a critical role in neutron capture therapy, aiming to enhance treatment methodologies for various diseases.
Latest Patents
Tamanoi holds a patent for his pioneering work titled "Biodegradable nanocarrier(s) (BPMOs) for neutron capture therapy and methods thereof." This patent details the creation of Biodegradable Periodic Mesoporous Organosilica (BPMO) nanomaterials, which can be loaded with Neutron Capture Agents. This innovative approach provides new methods for treating cancer and immunological disorders through effective Neutron Capture Therapy modalities.
Career Highlights
Tamanoi's dedication to his field is further exemplified by his role at Tae Life Sciences, LLC, where he continues to develop cutting-edge solutions in medical technology. His expertise in creating sustainable and effective treatment options underscores his commitment to improving patient outcomes through innovative research.
Collaborations
Through his work at Tae Life Sciences, Tamanoi has had the opportunity to collaborate with various professionals in the biomedical and engineering domains, advancing the integration of nanotechnology in therapeutic applications. These collaborations have been vital in enhancing the effectiveness of his patented technologies.
Conclusion
Fuhuhiko Tamanoi's contributions to the realm of biomedical engineering demonstrate his innovative spirit and dedication to fighting diseases through advanced treatment methodologies. His patent on biodegradable nanocarriers represents a significant step forward in cancer treatment and highlights the potential of nanotechnology in healthcare. As research continues to evolve, Tamanoi's work will likely inspire future innovations in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile